Detection of Mutant Circulating Tumor DNA (ctDNA) in Plasma of Patients With Colorectal Cancer (CRC)

被引：0
|
作者：
Dworniczak, Juliane
Rossenbach, Christiana
Reisch, Simone
Hart, Christian
Fuzesi, Laszlo
Dockhorn-Dworniczak, Barbara
Dworniczak, Bernd
机构：
[1] Tech Univ Munich, D-80290 Munich, Germany
[2] Inst Pathol, Kempten, Germany
[3] Klinikum Kempten, Kempten, Germany
[4] Univ Hosp Muenster, Munster, Germany
来源：
LABORATORY INVESTIGATION | 2015年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
2061
引用
收藏
页码：513A / 513A
页数：1
相关论文
共 50 条
  • [41] Detection of free-circulating tumor DNA in plasma of patients with gastrointestinal cancer
    Bruno, L.
    Augello, C.
    Sisto, P. S.
    Corsale, S.
    Gargano, G.
    Calo, V.
    La Rocca, G.
    Agnese, V.
    Cammareri, P.
    Cascio, S.
    Gregorio, V.
    Agnello, G.
    Valerio, M. R.
    Cicero, G.
    Di Fede, G.
    Martorana, A.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 156 - 156
  • [42] The role of determining the diagnostic value of circulating tumor DNA (ctDNA) and natural blood killers (NK) in the diagnosis of precancerous diseases of the colon and colorectal cancer (CRC)
    Turkpenova, I.
    Kaidarova, D.
    Smagulova, K. K.
    Jumanov, A.
    Orazgalieva, M.
    Amankulov, Z.
    Kadyrbaeva, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S61 - S61
  • [43] Circulating tumor DNA (ctDNA) for detection of molecular residual disease (MoRD) in breast cancer
    Austin, L.
    Jaslow, R.
    Fortina, P.
    Nagy, R.
    Zill, O.
    Talasaz, A.
    Cristofanilli, M.
    CANCER RESEARCH, 2016, 76
  • [44] Efficacy of circulating tumor DNA (ctDNA) analysis in the early detection of ovarian cancer progression
    Heo, J.
    Kim, Y. N.
    Lee, J. Y.
    Lee, S. T.
    Shin, S.
    Lee, Y. J.
    Kim, S. W.
    Choi, J. R.
    Kim, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S746 - S746
  • [45] Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
    MS Kopreski
    FA Benko
    C Kwee
    KE Leitzel
    E Eskander
    A Lipton
    CD Gocke
    British Journal of Cancer, 1997, 76 : 1293 - 1299
  • [46] Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
    Kopreski, MS
    Benko, FA
    Kwee, C
    Leitzel, KE
    Eskander, E
    Lipton, A
    Gocke, CD
    BRITISH JOURNAL OF CANCER, 1997, 76 (10) : 1293 - 1299
  • [47] The potential role of circulating tumor DNA (ctDNA) in the further investigation of colorectal cancer patients with nonspecific findings on standard investigations
    Wong, Rachel
    Tie, Jeanne
    Lee, Margaret
    Cohen, Joshua
    Wang, Yuxuan
    Li, Lu
    Ma, Stephen
    Christie, Michael
    Kosmider, Suzanne
    Tomasetti, Cristian
    Papadopoulos, Nickolas
    Kinzler, Kenneth W.
    Vogelstein, Bert
    Gibbs, Peter
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (02) : 540 - 547
  • [48] Relationship of circulating tumor DNA (ctDNA) tumor fraction with prognosis in patients with metastatic pancreatobiliary cancer
    Pathak, Priyadarshini
    Li, Gerald
    Quintanilha, Julia
    Keller-Evans, Rachel B.
    Pasquina, Lincoln W.
    Thierauf, Julia
    Elvin, Julia A.
    Ross, Jeffrey S.
    Graf, Ryon P.
    Parikh, Aparna Raj
    Pishvaian, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL)
  • [49] Circulating tumor DNA (ctDNA) trajectories predict survival in trifluridine/tipiracil-treated metastatic colorectal cancer patients
    Unseld, Matthias
    Kuehberger, Stefan
    Graf, Ricarda
    Beichler, Christine
    Braun, Markus
    Dandachi, Nadia
    Heitzer, Ellen
    Prager, Gerald W.
    MOLECULAR ONCOLOGY, 2025,
  • [50] Relationship of tumor fraction in circulating tumor DNA (ctDNA) with prognosis in patients with advanced urothelial cancer
    Miron, B.
    Li, G.
    Clark, A.
    Pasquina, L.
    Graf, R. P.
    Oxnard, G.
    ANNALS OF ONCOLOGY, 2023, 34 : S1220 - S1220
12345